Tag: biotechnology
Curative received FDA emergency use authorization for its novel COVID-19 tests
The diagnostics startup Curative has received an emergency use authorization from the Food and Drug Administration for its novel test to determine COVID-19 infection. The company says that its tests have already been used by the City of Los Angeles since late March and have tested over 53,000 city residents.…
Read More
Mammoth Biosciences receives first peer-reviewed validation of CRISPR-based COVID-19 test
SF-based CRISPR diagnostics startup Mammoth Biosciences has published the first peer-reviewed study that shows validation of using its testing method to detect the presence of COVID-19 in patients. The study, published in Nature, shows performance on par with existing PCR-based molecular tests, the one ones currently authorized for use by…
Read More
Flagship Pioneering raises $1.1 billion to spend on sustainability and health-focused biotech
Flagship Pioneering, the Boston-based biotech company incubator and holding company, said it has raised $1.1 billion for its Flagship Labs unit. Flagship, which raised $1 billion back in 2019 for growth stage investment vehicles, develops and operates startups that leverage biotechnology innovation to provide goods and services that improve human…
Read More
ARCH Venture Partners raises $1.46 billion across two funds for biotech investing
Against a backdrop where the life-or-death consequences of biotechnology innovation are becoming increasingly apparent as the world races to develop vaccines and therapies to treat COVID-19, life sciences investor ARCH Venture Partners has raised $1.46 billion in funding to finance new tech development. The two funds, ARCH Venture Fund X…
Read More
Aspen Neuroscience raises $70 million for its experimental Parkinson Disease treatment
Since 2012, Dr. Jeanne Loring, the founder of the eponymous Loring Lab at Scripps Research, has been thinking about how to use pluripotent stem cells as a potential treatment for Parkinson Disease. Now, eight years later, Aspen Neuroscience, the company she founded to bring her research to market has raised…
Read More
Cell and gene therapy startup ElevateBio raises $170 million
While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing round closures with significant money committed. Cambridge-based ElevateBio, for instance, revealed a $170 million Series B funding on Monday, with participation from new investors The Invus…
Read More